Visceral leishmaniasis and lymphoma: a rare and dangerous couple

Submitted: 25 October 2024
Accepted: 1 November 2024
Published: 10 March 2025
Abstract Views: 115
PDF: 51
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania. The vectors are hematophagous (blood-feeding) dipterans of various genera, with humans serving as accidental definitive hosts and, in some cases, as reservoirs. Visceral leishmaniasis more often affects immunocompromised individuals, in whom the protozoan invades and replicates within the host’s macrophages, evading innate and cell-mediated immune responses. We describe the case of a 54-year-old male patient who had not traveled to endemic areas. He presented with progressive asthenia associated with persistent fever, which had been treated at home with nonsteroidal anti-inflammatory drugs and oral betamethasone. During hospitalization, he developed cytopenia and hepatosplenomegaly. Bone marrow biopsy revealed the presence of Leishmania and intravascular large B-cell lymphoma. When faced with cases of fever of unknown origin, clinicians should also investigate opportunistic infections. An underlying condition causing immunosuppression may not be clear, and corticosteroids often alter hematological values, thus masking a hematological disease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Jeronimo SMB, de Queiroz Sousa A, Pearson RD. Leishmaniasis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens and practice. 3rd ed. Philadelphia, PA, USA: Saunders Elsevier; 2011. DOI: https://doi.org/10.1016/B978-0-7020-3935-5.00100-2
World Health Organization. WHO Classification of tumours of haematopoietic and lymphoid tissues. 2017. Available from: https://www.iarc.who.int/news-events/who-classification-of-tumours-of-haematopoietic-and-lymphoid-tissues-2/.
Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116:3724-34. DOI: https://doi.org/10.1182/blood-2010-05-282632
Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press; 2017.
Flowers CR, Sinha R, Vose JM. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin 2010;60:393-408. DOI: https://doi.org/10.3322/caac.20087
Kalmi G, Vignon-Pennamen MD, Ram-Wolff C, et al. Visceral leishmaniasis in patients with lymphoma: Case reports and review of the literature. Medicine 2020;99:e22787. DOI: https://doi.org/10.1097/MD.0000000000022787
Wright WF, Betz JF, Auwaerter PG. Prospective studies comparing structured vs nonstructured diagnostic protocol evaluations among patients with fever of unknown origin: a systematic review and meta-analysis. JAMA Netw Open 2022;5:e2215000. DOI: https://doi.org/10.1001/jamanetworkopen.2022.15000
Da Silva MRB, Stewart JM, Costa CH. Sensitivity of bone marrow aspirates in the diagnosis of visceral leishmaniasis. Am J Trop Med Hyg 2005;72:811-4. DOI: https://doi.org/10.4269/ajtmh.2005.72.811
Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31. DOI: https://doi.org/10.1002/pbc.21039
Prasad Sah S, Rijal S, Bhadani PP, et al. Visceral leishmaniasis in two cases of leukemia. Southeast Asian J Trop Med Public Health 2002;33:25-7.

How to Cite

Battino, N., & Pisano, A. (2025). Visceral leishmaniasis and lymphoma: a rare and dangerous couple. Italian Journal of Medicine, 19(1). https://doi.org/10.4081/itjm.2025.1843